The heightened awareness around the anti-malaria drug hydroxychloroquine as well as other experimental treatments for COVID-19 has led to reports of risky behaviors, according to
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
